Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 5
1996 8
1997 8
1998 58
1999 55
2000 56
2001 59
2002 68
2003 69
2004 74
2005 53
2006 59
2007 69
2008 48
2009 33
2010 33
2011 21
2012 26
2013 24
2014 14
2015 12
2016 10
2017 12
2018 7
2019 4
2020 19
2021 13
2022 11
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

885 results

Results by year

Filters applied: . Clear all
Page 1
Fosamprenavir.
[No authors listed] [No authors listed] 2017 Sep 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Sep 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643343 Free Books & Documents. Review.
Amprenavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS). Fosamprenavir is a prodrug of amprenavir that has better oral bioavailability and
Amprenavir is an antiretroviral protease inhibitor used in the therapy and prevention of human immunodeficiency virus (HIV) infection
Amprenavir (Agenerase).
Simmons P. Simmons P. Res Initiat Treat Action. 1999 Jul 1;5(3):7-10. Res Initiat Treat Action. 1999. PMID: 11366726
Amprenavir (Agenerase) received accelerated approval from the Food and Drug Administration (FDA) in April 1999. ...
Amprenavir (Agenerase) received accelerated approval from the Food and Drug Administration (FDA) in April 1999. ...
Amprenavir.
Adkins JC, Faulds D. Adkins JC, et al. Drugs. 1998 Jun;55(6):837-42; discussion 843-4. doi: 10.2165/00003495-199855060-00015. Drugs. 1998. PMID: 9617598 Review.
Amprenavir is a viral protease inhibitor with specificity for the HIV protease enzyme. The resistance profile of amprenavir appears to differ from that of other protease inhibitors such as saquinavir and indinavir. ...
Amprenavir is a viral protease inhibitor with specificity for the HIV protease enzyme. The resistance profile of amprenavir ap
Amprenavir (Agenerase).
[No authors listed] [No authors listed] Res Initiat Treat Action. 2000 Mar;6(1):32-3. Res Initiat Treat Action. 2000. PMID: 11708186 No abstract available.
[A novel anti-HIV agent--agenerase].
Ershov FI, Kas'ianova NV, Vasil'ev AN. Ershov FI, et al. Antibiot Khimioter. 2002;47(8):29-31. Antibiot Khimioter. 2002. PMID: 12515094 Review. Russian. No abstract available.
Agenerase approved by FDA.
Gaylord G. Gaylord G. Posit Living. 1999 May;8(4):6. Posit Living. 1999. PMID: 12492061 No abstract available.
Antiretrovirals.
Temesgen Z, Wright AJ. Temesgen Z, et al. Mayo Clin Proc. 1999 Dec;74(12):1284-301. doi: 10.4065/74.12.1284. Mayo Clin Proc. 1999. PMID: 10593358 Review.
Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.
Eke AC, Wang J, Amin K, Shapiro DE, Stek A, Smith E, Chakhtoura N, Basar M, George K, Knapp KM, João EC, Rungruengthanakit K, Capparelli E, Burchett S, Mirochnick M, Best BM; P1026s Protocol Team. Eke AC, et al. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02260-19. doi: 10.1128/AAC.02260-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015036 Free PMC article. Clinical Trial.
Plasma concentrations of amprenavir and ritonavir were measured using high-performance liquid chromatography. ...Although amprenavir plasma concentrations in women receiving ritonavir-boosted fosamprenavir were lower during pregnancy than postpartum, the reduced …
Plasma concentrations of amprenavir and ritonavir were measured using high-performance liquid chromatography. ...Although amprenav
885 results